79068397 - GEX

Information

• Trademark
• 79068397

• Source

• Serial Number

  79068397

• Registration Number

  3870245

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  November 27, 2008
  16 years ago

• Registration Date

  November 02, 2010
  14 years ago

• Transaction Date

  October 02, 2022
  2 years ago

• Status Date

  October 30, 2021
  3 years ago

• Published for Opposition Date

  August 17, 2010
  14 years ago

• Location Date

  October 30, 2021
  3 years ago

• Status Code

  707

• Employee Name

  MORRIS, KRISTINA KLOIB

• Attorney Docket Number

  S14321

  Attorney Name

  Leigh Ann Lindquist

  Law Office Assigned Location Code

  M70

• Owners

  • Glycotope GmbH

Case File Statements

• A00002: In the statement, Page 2, line 17 through line 22, "sanitary preparations for medical purposes; dietetic foods adapted for medical use; food for babies; medical plasters; materials for medical dressings; materials for dental filling and impression materials for dental purposes; disinfectants for sanitary purposes; preparations for destroying vermin; fungicides, herbicides; adjuvants for medical purposes; " is deleted. In the statement Page 2, line 23, "and veterinary" is deleted. In the statement, Page 2, line 25, "allergies, cardiovascular diseases," is deleted. In the statement, Page 2, line 25 through line 26, "neurological diseases" is deleted.
• A00001: In the statement, Page 1, line 35, through 39 is deleted. In the statement, Page 2, line 1, "microorganism and" is deleted. In the statement, Page 2, line 4, "microorganism or" is deleted. In the statement, Page 3, line 27, "bacteria" is deleted. In the statement, Page 3, line 30, "bacteria" is deleted. In the statement, Page 3, line 37, "chemistry" is deleted. In the statement, Page 3, line 49 "and microorganisms" is deleted. In the statement, Page 3, lines 53-54, "microorganisms and" is deleted.
• A00003: In the statement, Page 2, line 13 through line 57 is deleted, and Page 3, line 1 through line 20 is deleted, and, medicines for human purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine is inserted.
• GS0051: [ Pharmaceutical and veterinary preparations for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; sanitary preparations for medical purposes; dietetic foods adapted for medical use; food for babies; medical plasters; materials for medical dressings; materials for dental filling and impression materials for dental purposes; disinfectants for sanitary purposes; preparations for destroying vermin; fungicides, herbicides; adjuvants for medical purposes; Medicines for human and veterinary purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, [ allergies, cardiovascular diseases, ] infectious diseases, [ neurological diseases, ] gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; biological preparations for medical purposes; dietetic food adapted for medical purposes; enzyme, proteins, antibodies, cells, microorganisms as well as fragments, fractions, elements and lysates thereof for medical purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine, and as nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; vaccines; carbohydrates for medical purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; cultures of microorganisms for medical or veterinary purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; cultures of human cells for medical or veterinary purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; medical drinks for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; microorganisms, cells and preparations containing elements, fragments, fractions and lysates of microorganisms or cells for medical and veterinary purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; biological therapeutics, namely, therapeutics containing cells, microorganisms, proteins, glycoproteins, peptides, glycopeptides or modified or conjugated versions thereof ; milk ferments for pharmaceutical purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; nutritional additives and nutritional supplement additives for medical purposes for use in foods and dietary supplements for human consumption; nutrients for medical purposes, namely, enzymes, proteins, antibodies, cells, microorganisms as well as fragments, fractions, elements and lysates thereof as nutritional additives; sugar and carbohydrates for medical purposes, namely, therapeutically and prophylactically active sugar and carbohydrates, dietetic sugar and carbohydrates, sugar and carbohydrate replacements ]
• GS0011: [ Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry, except fungicides, herbicides, insecticides and parasiticides; unprocessed artificial resins; unprocessed plastics; fertilising preparations; fire extinguishing compositions; tempering and soldering chemicals; chemical substances for fermenting and preserving food stuffs; tanning agents for use in the manufacture of leather; adhesives used in industry; bacteria and cell preparations and elements, fragments, fractions and lysates thereof, except for medical or veterinary purposes, namely, for use in protein production, food manufacturing, scientific research, waste water treatment, bacteria and cell preparations for use in expression of engineered or glycosylated proteins and peptides; preparations containing bacteria and cells, except for medical or veterinary purposes, namely, for use in protein production, food manufacturing, scientific research, waste water treatment; biological preparations for laboratories, except for medical or veterinary purposes, namely, for use in bacterial and cell engineering, cultivation, harvesting, protein production; chemical preparations for analysis in laboratories, namely, preparations for protein, peptide, engineered proteins and peptides, glycoproteins, glycosylation, antibody or antigen analysis, preparations comprising antibody reagents used for the detection of antigens; chemical preparations for scientific purposes; chemical reagents except for medical or veterinary purposes and biological reagents in the nature of reagents for use in protein production, bacterial and cell engineering, cultivation and harvesting, probes for detecting and analyzing molecules in protein or nucleotide arrays, except for medical or veterinary purposes; diagnostic preparations, except for medical or veterinary purposes; enzymes, proteins and respective preparations for industrial purposes, namely, engineered proteins, glycosylated proteins, antibodies, enzymes for use in glycosylation, enzyme substrates, proteins used in the manufacture of cosmetics, beverages, food products and food supplements; ferments for chemical purposes, namely, yeast, bacterium, mold, or enzyme, that causes fermentation; in-vitro diagnostics, other than for medical purposes; carbohydrates for use in the manufacture of food and nutraceuticals; cultures of microorganisms and cells and elements, fragments, fractions and lysates thereof, other than for medical or veterinary purposes, namely, cultures of microorganisms and cells other than for medical and veterinary use, microorganism or cell cultures for use in protein production, food manufacturing, scientific research, waste water treatment, cultures of microorganisms or cells for use in expression of glycosylated proteins and peptides; expression systems for proteins and peptides comprising cells, particularly human cells and microorganisms suitable for expressing engineered or glycosylated proteins or peptides, or capable of providing optimized glycosylation; milk ferments for medical research purposes ]
• GS0421: Scientific and technological services and research and designer services relating thereto, namely, scientific research, scientific analysis, technology consultation and research, product development and optimization in the field of biotechnology, protein production, glycosylation, optimization of protein, antibody and enzyme activity, [ bacteria ] and cell engineering, cultivation and harvesting; industrial analysis and research services in the field of biotechnology, protein production, glycosylation, protein, antibody and enzyme activity, [ bacteria ] and cell engineering, cultivation and harvesting; [ design and development of computer hardware and software; ] biological research; services of a [ chemical or ] biological laboratory; [ technical surveys, namely, ] conducting biotechnology surveys, [ pharmacology surveys; ] conducting scientific surveys in the field of biotechnology, [ bacterial and ] cell engineering, protein production, glycosylation; research and development in the field of [ bacteriology, ] cytology, antibody technology, [ chemistry, ] immunology, [ cosmetics of expression systems in the nature of glycosylation of proteins, peptides, antibodies and enzymes, particularly for proteins and peptides; quality control; ] research and development of new products and technologies in the field of biotechnology, protein production, glycosylation, protein, antibody and enzyme activity, [ bacteria and ] cell engineering, cultivation and harvesting for others; technology and scientific consultancy in the field of biotechnology, protein production, glycosylation, protein, antibody and enzyme activity, [ bacteria and ] cell engineering, cultivation and harvesting; research and development in the field of glycomics, expression systems in the nature of glycosylation of proteins, peptides, antibodies and enzymes, development and improvement of cells, cell lines [ and microorganisms, ] antibody-engineering, optimised biological therapeutics, [ nutraceuticals, and food and nutritional supplements; ] research, quality control, technology consultancy and product development in the field of proteins, antibodies, [ microorganisms ] and cells; research and development in the field of [ microorganisms and ] cells

Case File Event Statements

• 10/2/2022 - 2 years ago

  60 - PARTIAL INVALIDATION PROCESSED BY THE IB Type: INNP

• 8/23/2022 - 2 years ago

  59 - PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INPS

• 8/23/2022 - 2 years ago

  58 - INVALIDATION PROCESSED Type: INPC

• 6/30/2022 - 2 years ago

  57 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INPR

• 10/30/2021 - 3 years ago

  56 - NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED Type: NA71

• 10/30/2021 - 3 years ago

  55 - REGISTERED - PARTIAL SEC 71 ACCEPTED Type: 71.P

• 10/28/2021 - 3 years ago

  54 - TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Type: EROP

• 5/6/2021 - 3 years ago

  53 - POST REGISTRATION ACTION MAILED - SEC.71 Type: PR71

• 1/20/2021 - 4 years ago

  52 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 11/2/2020 - 4 years ago

  51 - TEAS SECTION 71 RECEIVED Type: ES71

• 7/8/2020 - 4 years ago

  50 - AMENDMENT UNDER SECTION 7 ¿ PROCESSED Type: A7OK

• 12/16/2019 - 5 years ago

  49 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 12/16/2019 - 5 years ago

  48 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 11/2/2019 - 5 years ago

  47 - COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED Type: REM4

• 12/13/2018 - 6 years ago

  46 - INTERNATIONAL REGISTRATION RENEWED Type: RNWL

• 10/4/2018 - 6 years ago

  45 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 6/1/2018 - 6 years ago

  44 - TEAS SECTION 7 REQUEST RECEIVED Type: ES7R

• 3/30/2018 - 7 years ago

  43 - AMENDMENT UNDER SECTION 7 ¿ PROCESSED Type: A7OK

• 11/30/2017 - 7 years ago

  42 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 10/20/2017 - 7 years ago

  41 - TEAS SECTION 7 REQUEST RECEIVED Type: ES7R

• 6/23/2017 - 7 years ago

  40 - NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED Type: NA75

• 6/23/2017 - 7 years ago

  39 - REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. Type: C75A

• 6/20/2017 - 7 years ago

  38 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 4/27/2017 - 7 years ago

  37 - TEAS SECTION 71 & 15 RECEIVED Type: ES75

• 12/14/2013 - 11 years ago

  36 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 2/18/2013 - 12 years ago

  35 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 2/11/2011 - 14 years ago

  34 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 2/11/2011 - 14 years ago

  33 - FINAL DISPOSITION PROCESSED Type: FIMP

• 2/2/2011 - 14 years ago

  32 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 11/2/2010 - 14 years ago

  31 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 8/17/2010 - 14 years ago

  30 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 8/17/2010 - 14 years ago

  29 - PUBLISHED FOR OPPOSITION Type: PUBO

• 7/15/2010 - 14 years ago

  28 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 7/16/2010 - 14 years ago

  27 - EXAMINERS AMENDMENT MAILED Type: CNEA

• 7/15/2010 - 14 years ago

  26 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 7/15/2010 - 14 years ago

  25 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 7/15/2010 - 14 years ago

  24 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 7/15/2010 - 14 years ago

  23 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 7/15/2010 - 14 years ago

  22 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 7/15/2010 - 14 years ago

  21 - EXAMINERS AMENDMENT MAILED Type: CNEA

• 7/15/2010 - 14 years ago

  20 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 7/15/2010 - 14 years ago

  19 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 7/15/2010 - 14 years ago

  18 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 1/20/2010 - 15 years ago

  17 - FINAL REFUSAL MAILED Type: CNFR

• 1/19/2010 - 15 years ago

  16 - FINAL REFUSAL WRITTEN Type: CNFR

• 12/31/2009 - 15 years ago

  15 - CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED Type: CORN

• 1/1/2010 - 15 years ago

  14 - CORRECTION TRANSACTION RECEIVED FROM IB Type: CRCV

• 12/28/2009 - 15 years ago

  13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/28/2009 - 15 years ago

  12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/28/2009 - 15 years ago

  11 - ASSIGNED TO LIE Type: ALIE

• 12/14/2009 - 15 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 7/10/2009 - 15 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 6/15/2009 - 15 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 6/15/2009 - 15 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 6/13/2009 - 15 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 6/12/2009 - 15 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 6/9/2009 - 15 years ago

  4 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 6/5/2009 - 15 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 6/5/2009 - 15 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 6/4/2009 - 15 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR